Accuray Net Profit Margin 2012-2025 | ARAY
Accuray net profit margin from 2012 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Accuray Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-09-30 | $0.45B | $-0.02B | -4.21% |
| 2025-06-30 | $0.46B | $0.00B | -0.22% |
| 2025-03-31 | $0.47B | $0.00B | 0.22% |
| 2024-12-31 | $0.45B | $0.00B | -0.88% |
| 2024-09-30 | $0.44B | $-0.02B | -3.83% |
| 2024-06-30 | $0.45B | $-0.02B | -3.59% |
| 2024-03-31 | $0.43B | $-0.02B | -5.12% |
| 2023-12-31 | $0.45B | $-0.02B | -3.36% |
| 2023-09-30 | $0.46B | $-0.01B | -1.54% |
| 2023-06-30 | $0.45B | $-0.01B | -2.01% |
| 2023-03-31 | $0.44B | $-0.01B | -2.05% |
| 2022-12-31 | $0.42B | $-0.01B | -2.64% |
| 2022-09-30 | $0.42B | $-0.01B | -2.15% |
| 2022-06-30 | $0.43B | $-0.01B | -1.17% |
| 2022-03-31 | $0.43B | $-0.01B | -3.02% |
| 2021-12-31 | $0.44B | $-0.01B | -2.75% |
| 2021-09-30 | $0.42B | $-0.01B | -1.67% |
| 2021-06-30 | $0.40B | $-0.01B | -1.52% |
| 2021-03-31 | $0.38B | $0.01B | 1.32% |
| 2020-12-31 | $0.38B | $0.01B | 2.12% |
| 2020-09-30 | $0.38B | $0.01B | 3.69% |
| 2020-06-30 | $0.38B | $0.01B | 1.30% |
| 2020-03-31 | $0.41B | $0.00B | 0.99% |
| 2019-12-31 | $0.41B | 0 | 0.00% |
| 2019-09-30 | $0.41B | $-0.02B | -3.88% |
| 2019-06-30 | $0.42B | $-0.02B | -3.83% |
| 2019-03-31 | $0.42B | $-0.02B | -3.86% |
| 2018-12-31 | $0.41B | $-0.02B | -5.83% |
| 2018-09-30 | $0.41B | $-0.02B | -5.85% |
| 2018-06-30 | $0.41B | $-0.02B | -5.93% |
| 2018-03-31 | $0.40B | $-0.03B | -6.95% |
| 2017-12-31 | $0.40B | $-0.02B | -6.00% |
| 2017-09-30 | $0.39B | $-0.03B | -7.22% |
| 2017-06-30 | $0.38B | $-0.03B | -7.55% |
| 2017-03-31 | $0.37B | $-0.03B | -8.45% |
| 2016-12-31 | $0.38B | $-0.03B | -6.67% |
| 2016-09-30 | $0.40B | $-0.02B | -5.56% |
| 2016-06-30 | $0.40B | $-0.03B | -6.27% |
| 2016-03-31 | $0.41B | $-0.02B | -5.91% |
| 2015-12-31 | $0.40B | $-0.03B | -7.02% |
| 2015-09-30 | $0.39B | $-0.03B | -8.25% |
| 2015-06-30 | $0.38B | $-0.04B | -10.79% |
| 2015-03-31 | $0.38B | $-0.05B | -11.84% |
| 2014-12-31 | $0.38B | $-0.05B | -12.40% |
| 2014-09-30 | $0.38B | $-0.04B | -11.20% |
| 2014-06-30 | $0.37B | $-0.04B | -9.73% |
| 2014-03-31 | $0.35B | $-0.05B | -12.75% |
| 2013-12-31 | $0.33B | $-0.07B | -21.71% |
| 2013-09-30 | $0.31B | $-0.10B | -30.55% |
| 2013-06-30 | $0.32B | $-0.10B | -32.49% |
| 2013-03-31 | $0.33B | $-0.10B | -31.23% |
| 2012-12-31 | $0.36B | $-0.09B | -24.18% |
| 2012-09-30 | $0.39B | $-0.07B | -17.60% |
| 2012-06-30 | $0.41B | $-0.07B | -17.60% |
| 2012-03-31 | $0.38B | $-0.08B | -20.10% |
| 2011-12-31 | $0.34B | $-0.06B | -18.75% |
| 2011-09-30 | $0.28B | $-0.05B | -17.25% |
| 2011-06-30 | $0.22B | $-0.03B | -12.16% |
| 2011-03-31 | $0.21B | $0.00B | 1.44% |
| 2010-12-31 | $0.21B | $0.01B | 2.91% |
| 2010-09-30 | $0.21B | $0.00B | 0.48% |
| 2010-06-30 | $0.22B | $0.00B | 1.35% |
| 2010-03-31 | $0.22B | $0.00B | -0.46% |
| 2009-12-31 | $0.23B | $0.00B | -0.88% |
| 2009-09-30 | $0.23B | 0 | 0.00% |
| 2009-06-30 | $0.23B | 0 | 0.00% |
| 2009-03-31 | $0.23B | $0.00B | -0.44% |
| 2008-12-31 | $0.22B | $0.00B | -0.45% |
| 2008-09-30 | $0.22B | 0 | 0.00% |
| 2008-06-30 | $0.21B | $0.01B | 2.37% |
| 2008-03-31 | $0.20B | $-0.01B | -2.94% |
| 2007-12-31 | $0.18B | $-0.01B | -4.40% |
| 2007-09-30 | $0.16B | $-0.02B | -10.90% |
| 2007-06-30 | $0.14B | $-0.02B | -12.14% |
| 2007-03-31 | $0.11B | $-0.01B | -12.50% |
| 2006-12-31 | $0.09B | $-0.02B | -24.42% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.099B | $0.459B |
| Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing ongoing services and upgrades to customers following installation of the CyberKnife System. Product revenues include sales of linacs for other uses. It also offers optional hardware and software, technical enhancements and upgrades to the CyberKnife & TomoTherapy System. The CyberKnife Systems include: the CyberKnife G4, CyberKnife VSI System and the new CyberKnife M6 Series System. TomoTherapy Systems include the Hi-Art System, delivering CT-guided, helical intensity modulated radiation therapy; the TomoHD System and the Tomo H Series Systems. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $231.230B | 27.48 |
| Intuitive Surgical (ISRG) | United States | $205.316B | 80.33 |
| IDEXX Laboratories (IDXX) | United States | $57.873B | 57.47 |
| Edwards Lifesciences (EW) | United States | $48.171B | 32.30 |
| IQVIA Holdings (IQV) | United States | $41.018B | 22.87 |
| Alcon (ALC) | Switzerland | $39.884B | 26.95 |
| Mettler-Toledo (MTD) | United States | $30.479B | 35.66 |
| DexCom (DXCM) | United States | $27.683B | 38.16 |
| STERIS (STE) | Ireland | $25.594B | 26.42 |
| Waters (WAT) | United States | $23.443B | 31.00 |
| Coloplast (CLPBY) | Denmark | $20.255B | 34.57 |
| Hologic (HOLX) | United States | $16.687B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.899B | 0.00 |
| Penumbra (PEN) | United States | $12.511B | 88.01 |
| Globus Medical (GMED) | United States | $12.276B | 25.76 |
| Masimo (MASI) | United States | $7.103B | 22.76 |
| Sysmex ADR (SSMXY) | Japan | $6.421B | 20.40 |
| Glaukos (GKOS) | United States | $6.370B | 0.00 |
| Teleflex (TFX) | United States | $4.798B | 7.65 |
| TransMedics (TMDX) | United States | $4.602B | 54.52 |
| Veracyte (VCYT) | United States | $3.435B | 39.14 |
| LivaNova (LIVN) | United Kingdom | $3.406B | 18.40 |
| Integer Holdings (ITGR) | United States | $2.928B | 13.74 |
| Alphatec Holdings (ATEC) | United States | $2.613B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.407B | 22.52 |
| Artivion (AORT) | United States | $2.032B | 93.24 |
| UFP Technologies (UFPT) | United States | $1.997B | 26.36 |
| Nihon Kohden (NHNKY) | Japan | $1.986B | 17.34 |
| PROCEPT BioRobotics (PRCT) | United States | $1.751B | 0.00 |
| AxoGen (AXGN) | United States | $1.455B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.448B | 0.00 |
| IRadimed (IRMD) | United States | $1.245B | 59.33 |
| Integra LifeSciences Holdings (IART) | United States | $1.024B | 5.55 |
| OPKO Health (OPK) | United States | $1.021B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.987B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.777B | 0.00 |
| SiBone (SIBN) | United States | $0.775B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.667B | 38.79 |
| Pacific Biosciences Of California (PACB) | United States | $0.607B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.604B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.601B | 0.00 |
| NeuroPace (NPCE) | United States | $0.563B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.556B | 11.08 |
| OrthoPediatrics (KIDS) | United States | $0.504B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.464B | 12.80 |
| ClearPoint Neuro (CLPT) | United States | $0.445B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.420B | 0.00 |
| RxSight (RXST) | United States | $0.415B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.392B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.363B | 60.53 |
| Semler Scientific (SMLR) | United States | $0.344B | 2.57 |
| Spectral Diagnostics (EDTXF) | Canada | $0.299B | 0.00 |
| 908 Devices (MASS) | United States | $0.198B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.196B | 0.00 |
| CVRx (CVRX) | United States | $0.192B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.187B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.178B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.164B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.153B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.150B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.143B | 0.00 |
| LENSAR (LNSR) | United States | $0.138B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.136B | 0.00 |
| Neuronetics (STIM) | United States | $0.136B | 0.00 |
| Solana (HSDT) | United States | $0.133B | 0.00 |
| Hyperfine (HYPR) | United States | $0.099B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.084B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.065B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.035B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Envoy Medical (COCH) | United States | $0.021B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.46 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |